Christ T, Dobrev D, Wallukat G, Schüler S, Ravens U
Department of Pharmacology and Toxicology, Max-Delbrück Centre for Molecular Medicine, Berlin, Germany.
Methods Find Exp Clin Pharmacol. 2001 Apr;23(3):141-4. doi: 10.1358/mf.2001.23.3.627947.
In two recent studies immunoadsorption improved left ventricular function in patients with dilated cardiomyopathy (DCM) who were positive for cardiostimulatory autoantibodies against the human beta 1-adrenoceptor (beta 1-AAB). In this study we invasively measured acute hemodynamics during immunoadsorption. Three patients with DCM, who were positive for beta 1-AAB (NYHA-class III, left ventricular ejection fraction < 0.3), were treated with 1 immunoadsorption session daily on 5 consecutive days. Immunoadsorption induced a strong decrease of cardiac index, whereas systemic vascular resistance increased. Baseline levels were reached again several hours after therapy ended. We conclude that during immunoadsorption substantial hemodynamic changes occur in patients positive for beta 1-AAB.
在最近的两项研究中,免疫吸附改善了扩张型心肌病(DCM)患者的左心室功能,这些患者针对人β1 -肾上腺素能受体(β1 -AAB)的心脏刺激自身抗体呈阳性。在本研究中,我们在免疫吸附过程中进行了有创性急性血流动力学测量。三名β1 -AAB呈阳性的DCM患者(纽约心脏协会III级,左心室射血分数<0.3),连续5天每天接受1次免疫吸附治疗。免疫吸附导致心脏指数大幅下降,而全身血管阻力增加。治疗结束数小时后再次达到基线水平。我们得出结论,在免疫吸附过程中,β1 -AAB呈阳性的患者会出现显著的血流动力学变化。